Report Detail
Global Hematopoietic Stem Cells (HSCs) Market Insights, Forecast to 2025
- RnM2350120 |
- 08 April, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
The global Hematopoietic Stem Cells (HSCs) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hematopoietic Stem Cells (HSCs) market based on company, product type, end user and key regions.
This report studies the global market size of Hematopoietic Stem Cells (HSCs) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hematopoietic Stem Cells (HSCs) in these regions.
This research report categorizes the global Hematopoietic Stem Cells (HSCs) market by top players/brands, region, type and end user. This report also studies the global Hematopoietic Stem Cells (HSCs) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Kite Pharma Inc.
Thermo Fisher Scientific
PromoCell
CellGenix Technologie Transfer GmbH
Cesca Therapeutics Inc.
R&D Systems
Genlantis
Lonza Group Ltd.
TiGenix N.V.
ScienCell Research Laboratories
China Cord Blood Corporation
Vcanbio
Boyalife
Beike Biotechnology
Market size by Product
Leukocyte
Lymphocytes
Red Blood Cells
Platelets
Market size by End User
Blood System Diseases
Autoimmune Diseases
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Hematopoietic Stem Cells (HSCs) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hematopoietic Stem Cells (HSCs) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hematopoietic Stem Cells (HSCs) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hematopoietic Stem Cells (HSCs) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Hematopoietic Stem Cells (HSCs) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hematopoietic Stem Cells (HSCs) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Hematopoietic Stem Cells (HSCs) Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Product
- 1.4.2 Leukocyte
- 1.4.3 Lymphocytes
- 1.4.4 Red Blood Cells
- 1.4.5 Platelets
- 1.5 Market by End User
- 1.5.1 Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by End User
- 1.5.2 Blood System Diseases
- 1.5.3 Autoimmune Diseases
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Hematopoietic Stem Cells (HSCs) Market Size
- 2.1.1 Global Hematopoietic Stem Cells (HSCs) Revenue 2014-2025
- 2.1.2 Global Hematopoietic Stem Cells (HSCs) Sales 2014-2025
- 2.2 Hematopoietic Stem Cells (HSCs) Growth Rate by Regions
- 2.2.1 Global Hematopoietic Stem Cells (HSCs) Sales by Regions
- 2.2.2 Global Hematopoietic Stem Cells (HSCs) Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Hematopoietic Stem Cells (HSCs) Sales by Manufacturers
- 3.1.1 Hematopoietic Stem Cells (HSCs) Sales by Manufacturers
- 3.1.2 Hematopoietic Stem Cells (HSCs) Sales Market Share by Manufacturers
- 3.1.3 Global Hematopoietic Stem Cells (HSCs) Market Concentration Ratio (CR5 and HHI)
- 3.2 Hematopoietic Stem Cells (HSCs) Revenue by Manufacturers
- 3.2.1 Hematopoietic Stem Cells (HSCs) Revenue by Manufacturers (2014-2019)
- 3.2.2 Hematopoietic Stem Cells (HSCs) Revenue Share by Manufacturers (2014-2019)
- 3.3 Hematopoietic Stem Cells (HSCs) Price by Manufacturers
- 3.4 Hematopoietic Stem Cells (HSCs) Manufacturing Base Distribution, Product Types
- 3.4.1 Hematopoietic Stem Cells (HSCs) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Hematopoietic Stem Cells (HSCs) Product Type
- 3.4.3 Date of International Manufacturers Enter into Hematopoietic Stem Cells (HSCs) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Hematopoietic Stem Cells (HSCs) Sales by Product
- 4.2 Global Hematopoietic Stem Cells (HSCs) Revenue by Product
- 4.3 Hematopoietic Stem Cells (HSCs) Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Hematopoietic Stem Cells (HSCs) Breakdown Data by End User
6 North America
- 6.1 North America Hematopoietic Stem Cells (HSCs) by Countries
- 6.1.1 North America Hematopoietic Stem Cells (HSCs) Sales by Countries
- 6.1.2 North America Hematopoietic Stem Cells (HSCs) Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Hematopoietic Stem Cells (HSCs) by Product
- 6.3 North America Hematopoietic Stem Cells (HSCs) by End User
7 Europe
- 7.1 Europe Hematopoietic Stem Cells (HSCs) by Countries
- 7.1.1 Europe Hematopoietic Stem Cells (HSCs) Sales by Countries
- 7.1.2 Europe Hematopoietic Stem Cells (HSCs) Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Hematopoietic Stem Cells (HSCs) by Product
- 7.3 Europe Hematopoietic Stem Cells (HSCs) by End User
8 Asia Pacific
- 8.1 Asia Pacific Hematopoietic Stem Cells (HSCs) by Countries
- 8.1.1 Asia Pacific Hematopoietic Stem Cells (HSCs) Sales by Countries
- 8.1.2 Asia Pacific Hematopoietic Stem Cells (HSCs) Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Hematopoietic Stem Cells (HSCs) by Product
- 8.3 Asia Pacific Hematopoietic Stem Cells (HSCs) by End User
9 Central & South America
- 9.1 Central & South America Hematopoietic Stem Cells (HSCs) by Countries
- 9.1.1 Central & South America Hematopoietic Stem Cells (HSCs) Sales by Countries
- 9.1.2 Central & South America Hematopoietic Stem Cells (HSCs) Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Hematopoietic Stem Cells (HSCs) by Product
- 9.3 Central & South America Hematopoietic Stem Cells (HSCs) by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Hematopoietic Stem Cells (HSCs) by Countries
- 10.1.1 Middle East and Africa Hematopoietic Stem Cells (HSCs) Sales by Countries
- 10.1.2 Middle East and Africa Hematopoietic Stem Cells (HSCs) Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Hematopoietic Stem Cells (HSCs) by Product
- 10.3 Middle East and Africa Hematopoietic Stem Cells (HSCs) by End User
11 Company Profiles
- 11.1 Kite Pharma Inc.
- 11.1.1 Kite Pharma Inc. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Products Offered
- 11.1.5 Kite Pharma Inc. Recent Development
- 11.2 Thermo Fisher Scientific
- 11.2.1 Thermo Fisher Scientific Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Products Offered
- 11.2.5 Thermo Fisher Scientific Recent Development
- 11.3 PromoCell
- 11.3.1 PromoCell Company Details
- 11.3.2 Company Business Overview
- 11.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 PromoCell Hematopoietic Stem Cells (HSCs) Products Offered
- 11.3.5 PromoCell Recent Development
- 11.4 CellGenix Technologie Transfer GmbH
- 11.4.1 CellGenix Technologie Transfer GmbH Company Details
- 11.4.2 Company Business Overview
- 11.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Products Offered
- 11.4.5 CellGenix Technologie Transfer GmbH Recent Development
- 11.5 Cesca Therapeutics Inc.
- 11.5.1 Cesca Therapeutics Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Products Offered
- 11.5.5 Cesca Therapeutics Inc. Recent Development
- 11.6 R&D Systems
- 11.6.1 R&D Systems Company Details
- 11.6.2 Company Business Overview
- 11.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 R&D Systems Hematopoietic Stem Cells (HSCs) Products Offered
- 11.6.5 R&D Systems Recent Development
- 11.7 Genlantis
- 11.7.1 Genlantis Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Genlantis Hematopoietic Stem Cells (HSCs) Products Offered
- 11.7.5 Genlantis Recent Development
- 11.8 Lonza Group Ltd.
- 11.8.1 Lonza Group Ltd. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Products Offered
- 11.8.5 Lonza Group Ltd. Recent Development
- 11.9 TiGenix N.V.
- 11.9.1 TiGenix N.V. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Products Offered
- 11.9.5 TiGenix N.V. Recent Development
- 11.10 ScienCell Research Laboratories
- 11.10.1 ScienCell Research Laboratories Company Details
- 11.10.2 Company Business Overview
- 11.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Products Offered
- 11.10.5 ScienCell Research Laboratories Recent Development
- 11.11 China Cord Blood Corporation
- 11.12 Vcanbio
- 11.13 Boyalife
- 11.14 Beike Biotechnology
12 Future Forecast
- 12.1 Hematopoietic Stem Cells (HSCs) Market Forecast by Regions
- 12.1.1 Global Hematopoietic Stem Cells (HSCs) Sales Forecast by Regions 2019-2025
- 12.1.2 Global Hematopoietic Stem Cells (HSCs) Revenue Forecast by Regions 2019-2025
- 12.2 Hematopoietic Stem Cells (HSCs) Market Forecast by Product
- 12.2.1 Global Hematopoietic Stem Cells (HSCs) Sales Forecast by Product 2019-2025
- 12.2.2 Global Hematopoietic Stem Cells (HSCs) Revenue Forecast by Product 2019-2025
- 12.3 Hematopoietic Stem Cells (HSCs) Market Forecast by End User
- 12.4 North America Hematopoietic Stem Cells (HSCs) Forecast
- 12.5 Europe Hematopoietic Stem Cells (HSCs) Forecast
- 12.6 Asia Pacific Hematopoietic Stem Cells (HSCs) Forecast
- 12.7 Central & South America Hematopoietic Stem Cells (HSCs) Forecast
- 12.8 Middle East and Africa Hematopoietic Stem Cells (HSCs) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Hematopoietic Stem Cells (HSCs) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Hematopoietic Stem Cells (HSCs) . Industry analysis & Market Report on Hematopoietic Stem Cells (HSCs) is a syndicated market report, published as Global Hematopoietic Stem Cells (HSCs) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Hematopoietic Stem Cells (HSCs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
